McDonald's Adjusts Its Menus - the Reason Is Obesity Drugs
4 Articles
4 Articles
With a new menu offer, McDonalds reacts to the boom of the weight loss syringes. 8.5 billion US dollars will be spent on the new strategy.
McDonalds wants to remain attractive in the Ozempic era – with smaller, more protein-rich courts. This should not only concern shareholders.
The popularity of diet pills is already visible on the menus of fast food chains.
McDonald's is considering changes to its offer due to the increasing use of drugs from the GLP-1 group, including Ozempik and Vegovi. The company is examining smaller and more customizable portions, meals with more protein and offers with less sugar, as millions of Americans are changing their diet under the influence of these preparations, "finance.yahoo.com" reports. McDonald's CEO Chris Kempczynski said that […] The article Less appetite, sma…
Coverage Details
Bias Distribution
- 67% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
